C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)

SHE:000950 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,974	9,392	9,149	7,422	5,665	4,605
Trading Asset Securities	-	-	-	6.9	12.4	87.5
Cash & Short-Term Investments	6,974	9,392	9,149	7,429	5,677	4,692
Cash Growth	9.27%	2.65%	23.15%	30.86%	20.98%	39.63%
Accounts Receivable	37,711	34,423	33,719	29,620	26,988	22,544
Other Receivables	1,553	1,893	1,443	1,389	1,243	922.07
Receivables	39,264	36,316	35,162	31,009	28,231	23,466
Inventory	9,900	9,977	8,603	7,863	6,051	5,653
Prepaid Expenses	-	-	-	19.44	-	-
Other Current Assets	3,065	1,735	1,621	2,388	1,379	1,285
Total Current Assets	59,203	57,420	54,534	48,708	41,338	35,096
Property, Plant & Equipment	2,638	2,624	2,626	2,650	2,557	1,850
Long-Term Investments	3,334	3,268	3,091	3,032	2,958	2,379
Goodwill	1,461	1,461	1,501	1,509	1,461	1,456
Other Intangible Assets	336.65	311.73	320.01	263.57	262.32	293.78
Long-Term Accounts Receivable	-	85.28	49.49	1.41	2.78	0.75
Long-Term Deferred Tax Assets	448.3	438.89	328.69	225.67	255	187.53
Long-Term Deferred Charges	173.14	178.7	173.63	123.41	105.23	90.78
Other Long-Term Assets	908.67	770.04	798.8	679.13	761.64	1,041
Total Assets	68,503	66,630	63,481	57,192	49,700	42,432
Accounts Payable	20,045	18,165	17,437	13,761	12,126	10,974
Accrued Expenses	127.84	678.31	583.19	523.3	492	440.14
Short-Term Debt	15,354	16,243	16,763	17,079	13,806	9,856
Current Portion of Long-Term Debt	2,970	2,364	1,540	3,799	430.56	871.57
Current Portion of Leases	-	166.37	170.72	154.9	156.81	-
Current Income Taxes Payable	241.68	111.48	139.08	126.97	155.39	192.84
Current Unearned Revenue	1,010	528.08	447.73	716.16	215.53	182.96
Other Current Liabilities	6,633	5,807	5,780	4,515	4,342	4,644
Total Current Liabilities	46,382	44,064	42,860	40,674	31,724	27,162
Long-Term Debt	4,619	5,370	4,439	3,123	5,434	4,012
Long-Term Leases	288.73	259.06	266.34	228.74	226.31	-
Long-Term Unearned Revenue	65.82	63.62	68.02	73.08	76.25	69.88
Long-Term Deferred Tax Liabilities	67.88	68.54	54.83	47.14	57.64	25.37
Other Long-Term Liabilities	405.64	287.01	274.16	280.13	357.31	625.87
Total Liabilities	51,829	50,167	48,016	44,481	37,934	31,952
Common Stock	1,728	1,728	1,728	1,743	1,743	1,728
Additional Paid-In Capital	2,472	2,481	2,494	2,436	2,437	2,366
Retained Earnings	7,351	7,225	7,081	6,560	5,720	4,783
Treasury Stock	-	-	-	-41.9	-41.9	-
Comprehensive Income & Other	-107.62	-107.62	-86.79	-45.76	-36.92	-42.19
Total Common Equity	11,443	11,327	11,216	10,652	9,821	8,836
Minority Interest	5,230	5,136	4,250	2,059	1,946	1,645
Shareholders' Equity	16,674	16,463	15,465	12,710	11,767	10,481
Total Liabilities & Equity	68,503	66,630	63,481	57,192	49,700	42,432
Total Debt	23,232	24,403	23,179	24,384	20,054	14,740
Net Cash (Debt)	-16,258	-15,012	-14,030	-16,955	-14,377	-10,047
Net Cash Per Share	-9.10	-8.49	-8.09	-9.79	-8.29	-5.81
Filing Date Shares Outstanding	1,728	1,728	1,728	1,743	1,692	1,728
Total Common Shares Outstanding	1,728	1,728	1,728	1,743	1,692	1,728
Working Capital	12,820	13,356	11,674	8,034	9,613	7,934
Book Value Per Share	6.62	6.55	6.49	6.11	5.81	5.11
Tangible Book Value	9,646	9,554	9,394	8,879	8,098	7,086
Tangible Book Value Per Share	5.58	5.53	5.44	5.09	4.79	4.10
Buildings	-	2,201	2,212	2,106	1,773	-
Machinery	-	1,236	1,128	956.1	736.98	-
Construction In Progress	-	67.63	1.76	169.58	474.58	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.